ACQUISITION OF BENEFICIAL OWNERSHIP

Company

Spyre Therapeutics, Inc.

Filed

July 3, 2023

Accession Number

0001839882-23-017505

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →